JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BUSSELL, L. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BUSSELL, L. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 69, Issue 2, 128-139, 1940
Copyright © 1940 by American Society for Pharmacology and Experimental Therapeutics


THE RELATION OF ATROPINE TO ADRENALINE AND THE SYMPATHETIC SYSTEM

L. J. BUSSELL 1

1 From the Department of Pharmacology, Oxford

1. Antagonism between atropine and adrenaline was demonstrated in dog's leg and rabbit ear perfusions, and for the nictitating membrane and blood pressure of spinal cats. Atropine also caused dilatation of the spleen and of the small intestine and a fall of blood pressure in cats under ether. Hyoscine, in the experiments tried, showed no antagonism to adrenaline.

2. Atropine caused a partial paralysis of the cervical sympathetic in rabbit ear perfusions, and of the cervical and thoracic sympathetic in spinal cats.

3. No antagonism was found between atropine and pituitary (posterior lobe) extract in rabbit ear perfusions.

4. It is pointed out that atropine is related chemically to cocaine, and the action of atropine described resembles that of large concentrations of cocaine which inhibit the action of adrenaline.

Submitted on February 24, 1940







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1940 by the American Society for Pharmacology and Experimental Therapeutics.